Laos Pharmaceuticals & Healthcare Q2 2018
Although Laos’s pharmaceutical spending will experience relatively high growth over the forecast period, the smallmarket size and a challenging operating operating environment will continue to limit growth opportunities for drugmakers seekingto commercialise products in the country. The rising burden of chronic conditions, together with the entrenched burden posed bycommunicable diseases, will ensure that demand for medical treatment remains high. While sustained economic growth willsupport pharmaceutical spending growth, low purchasing power means low-cost generic drugs will remain favouredamong patients in the near term.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook